Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-019805-41-IT
EUCTR2010-019805-41-IT
Active, not recruiting
Not Applicable

Pharmacogenomics in optimizing the chemotherapy in the treatment of colorectal carcinoma - AOBS-FOBERL-COBIOMAR

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA0 sitesJune 16, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOLORECTAL NEOPLASTIC DISEASEMedDRA version: 9.1Level: LLTClassification code 10009973MedDRA version: 9.1Level: LLTClassification code 10009974

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COLORECTAL NEOPLASTIC DISEASE
Sponsor
AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA

Eligibility Criteria

Inclusion Criteria

  • •? Male or female \> 18 years ? Histological diagnosis of colon or rectum adenocarcinoma ? Locally advanced or metastatic colorectal carcinoma candidate for chemotherapy and/or target therapy ? Signed informed consent ? Availability to reach the hospital
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •? Lack of histological diagnosis of colon or rectum adenocarcinoma ? Lack of signed informed consent ? \< 18 years ? Any other cancer except melanoma or cervical carcinoma in situ ? Previous chemotherapy treatment ? Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040
EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
Active, not recruiting
Not Applicable
Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1) - INDICES/WP2Healthy volunteers with special genotypesMedDRA version: 16.0Level: LLTClassification code 10053349Term: Pharmacokinetic studySystem Organ Class: 100000004848Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
EUCTR2011-004815-22-DKResearch Institute of Biological Psychiatry Sct. Hans
Completed
Not Applicable
Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"Carcinoma, Non-Small-Cell Lung
NCT00222404University Hospital, Grenoble556
Recruiting
Not Applicable
A study of determine if genes influence the response to chemotherapy in patients with cancer of the mouth
CTRI/2014/09/005002DBT12
Not yet recruiting
Phase 3
A study to see effectiveness of chemotherapy for older patients with lung cancer.Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecified
CTRI/2022/07/044193Tata Memorial Hospital